Association of ABCB1 and CYP2C19 polymorphisms with major adverse cardiovascular complications in patients taking clopidogrel

• by Lubna Q. Khasawneh, Mais N. Alqasrawi, Zeina N. Al-Mahayri, Lilas Dabaghie, Sahar M. Altoum, Gohar Jamil, Salahdein Aburuz, Dana Hamza, Lizy George, Faiz Al-Bakshy, Kaes Al-Anee, Khuzama AlAhamad, Fatma Al-Maskari, Husam Ouda, Juma AlKaabi, George P. Patrinos, Bassam R. Ali

• June 24, 2026

Side Effects: Variety Is Overrated

The organ you forgot, the cells that age unevenly, the AI that admits ignorance, and the diet advice that sounds wrong but isn't: medicine's next moves are hiding in plain sight.

• by Kerri Miller

• March 30, 2026

• 7 min

Type 1 and type 2 NSTEMI in atrial fibrillation: insights from the HERA-FIB registry

• by Mustafa Yildirim, Christian Salbach, Johannes Dürr, Matthias Mueller-Hennessen, Hugo A. Katus, Norbert Frey, Evangelos Giannitsis

• April 15, 2026

Cardiac Arrest Patterns After Holidays

Association strongest after multiday holidays and in several higher-risk patient groups.

• by Kathryn Wighton

• March 6, 2026

• 3 min